Publication: Dna vaccine administered by cationic lipoplexes or by in vivo electroporation induces comparable antibody responses against sars-cov-2 in mice
Issued Date
2021-08-01
Resource Type
ISSN
2076393X
Other identifier(s)
2-s2.0-85112459628
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Vaccines. Vol.9, No.8 (2021)
Suggested Citation
Allegra Peletta, Eakachai Prompetchara, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Teerasit Techawiwattanaboon, Tayeb Jbilou, Pratomporn Krangvichian, Sunee Sirivichayakul, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Kanitha Patarakul, Kiat Ruxrungtham, Chutitorn Ketloy, Gerrit Borchard Dna vaccine administered by cationic lipoplexes or by in vivo electroporation induces comparable antibody responses against sars-cov-2 in mice. Vaccines. Vol.9, No.8 (2021). doi:10.3390/vaccines9080874 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77246
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dna vaccine administered by cationic lipoplexes or by in vivo electroporation induces comparable antibody responses against sars-cov-2 in mice
Author(s)
Allegra Peletta
Eakachai Prompetchara
Kittipan Tharakhet
Papatsara Kaewpang
Supranee Buranapraditkun
Teerasit Techawiwattanaboon
Tayeb Jbilou
Pratomporn Krangvichian
Sunee Sirivichayakul
Suwimon Manopwisedjaroen
Arunee Thitithanyanont
Kanitha Patarakul
Kiat Ruxrungtham
Chutitorn Ketloy
Gerrit Borchard
Eakachai Prompetchara
Kittipan Tharakhet
Papatsara Kaewpang
Supranee Buranapraditkun
Teerasit Techawiwattanaboon
Tayeb Jbilou
Pratomporn Krangvichian
Sunee Sirivichayakul
Suwimon Manopwisedjaroen
Arunee Thitithanyanont
Kanitha Patarakul
Kiat Ruxrungtham
Chutitorn Ketloy
Gerrit Borchard
Other Contributor(s)
Abstract
In view of addressing the global necessity of an effective vaccine in the SARS-CoV-2 pandemic, a plasmid DNA vaccine, expressing for the spike (S) protein and formulated in lipoplexes, was manufactured and tested for in vitro transfection and in vivo immunogenicity. Blank cationic liposomes of 130.9 ± 5.8 nm in size and with a zeta potential of +48 ± 12 mV were formulated using the thin-film layer rehydration method. Liposomes were complexed with pCMVkan-S at different N/P ratios. Ratios of 0.25:1 and 1:1 were selected according to their complex stability and controlled size compared to other ratios and tested in vitro for transfection studies and in vivo for immunogenicity. Both selected formulations showed enhanced neutralizing antibody responses compared to pCMVkan-S injected alone, as well as an increased T cell response. The titers observed were similar to those of intramuscular electroporation (IM-EP), which was set as an efficacy goal.